Immunovant shareholder plans $7.4M stock sale

IMVT (reported by Morgan Stanley Smith Barney LLC Executive Financial Services) filed Form 144 reporting proposed sales of Common shares.

Rhea-AI Filing Summary

IMVT (reported by Morgan Stanley Smith Barney LLC Executive Financial Services) filed Form 144 reporting proposed sales of Common shares. The notice lists multiple proposed sale methods and dates, including exercise of options under a registered plan, restricted stock vesting, and an open market purchase.

The filing itemizes individual lot sizes on specific dates, including 16,260, 49,961, 77,181, and other share amounts; these are presented as proposed dispositions rather than aggregated totals.

Key Figures

Proposed lot - 1: 16,260 shares Proposed lot - 2: 49,961 shares Proposed lot - 3: 77,181 shares +3 more

6 metrics

Proposed lot - 1 16,260 shares Exercise of options under a registered plan on <date> 05/28/2026

Proposed lot - 2 49,961 shares Exercise of options under a registered plan on <date> 05/28/2026

Proposed lot - 3 77,181 shares Exercise of options under a registered plan on <date> 05/28/2026

Proposed lot - 4 21,531 shares Exercise of options under a registered plan on <date> 05/28/2026

Restricted stock vesting 12,350 shares Vesting under a registered plan on <date> 12/01/2023

Open market purchase 5,500 shares Open Market Purchase on <date> 08/10/2021

Key Terms

Form 144, Exercise of options under a registered plan, Restricted stock vesting under a registered plan, Open Market Purchase

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of options under a registered plan financial

"Securities To Be Sold | Exercise of options under a registered plan"

Restricted stock vesting under a registered plan financial

"Securities To Be Sold | Restricted stock vesting under a registered plan"

Open Market Purchase market

"Securities To Be Sold | Open Market Purchase"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 04:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001341896
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMMUNOVANT, INC.
SEC File Number	001-38906
Address of Issuer	1000 Park Forty Plaza, Suite 210 Durham NORTH CAROLINA 27713
Phone	(917) 410-3120
Name of Person for Whose Account the Securities are To Be Sold	ANDREW J FROMKIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	221951	7438709.96	205309000	05/28/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/28/2026	Exercise of options under a registered plan	Issuer			16260	05/28/2026	Cash
Common	05/28/2026	Exercise of options under a registered plan	Issuer			49961	05/28/2026	Cash
Common	08/10/2021	Open Market Purchase	Open Market			5500	08/10/2021	Cash
Common	05/28/2026	Exercise of options under a registered plan	Issuer			31668	05/28/2026	Cash
Common	12/01/2023	Restricted stock vesting under a registered plan	Issuer			12350	12/01/2023	Services Rendered
Common	12/01/2024	Restricted stock vesting under a registered plan	Issuer			7500	12/01/2024	Services Rendered
Common	05/28/2026	Exercise of options under a registered plan	Issuer			77181	05/28/2026	Cash
Common	05/28/2026	Exercise of options under a registered plan	Issuer			21531	05/28/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/28/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew J Fromkin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)